Optic Neuritis Drug Market By Type ( Oral corticosteroid, Intravenous corticosteroid ), By End-user ( Adult, Pediatric ), By Distribution Channel ( Hospitals, Ophthalmic clinics, Ambulatory surgical centers ), Industry Trends, Estimation & Forecast, 2017 - 2025

Check Today's Best Price

$3500 Buy Now
Optic Neuritis Drug Market is expected to grow with a CAGR of XX% during the forecast period of 2018 to 2025.
  • Market Overview:

    Optic neuritis is the inflammation of optic nerves that can result into optic neuropathy. It is a serious condition which if not treated well can result into multiple sclerosis. An estimate of 15-20% of the people suffering from optic neuritis are likely to end up suffering with multiple sclerosis. However, only 3% of the population suffering from optic neuritis are expected to lose complete vision and go blind. As per the Optic Neuritis Foundation Inc., adults between the ages of 18-45 years are most prone to such a condition. Females are said to be more prone to optic nerve inflammation as compared to the male gender. As per the research studies, approximately 115 out of 100,00 people have optic neuritis condition in the whole world.

    The treatment for optic neuritis, which is also called as optic papillitis, is carried out by the consumption of prescribed corticosteroid drugs. The corticosteroid drugs are administered via both intravenous and oral route of administration. The global optic neuritis drug market is expected to witness hurdles in its growth during the upcoming years, owing to the lack of awareness among the common populace regarding optic neuritis and its treatment. In addition, the side-effects of oral consumption of corticosteroids for longer duration can lead to osteoporosis, hypertension, diabetes, and cataract among few others. This in turn diminishes the growth of the global market. However, increasing number of initiatives are being taken for spreading awareness regarding optic neuritis, along with increasing investments for the research and development of optic neuritis drugs. Such measures are anticipated to fuel the growth of the global optic neuritis drug market and offer lucrative opportunities to the market players.

    The report provides detailed qualitative and quantitative analysis of the global optic neuritis drug market. Market size and forecast in terms of value and volume has been provided for the period – (2017 – 2025), for the segments namely type, and end-use in each of the major regions of the world.

    Optic Neuritis Drug Market Segmentation

    By Type
    • Oral corticosteroid
    • Intravenous corticosteroid
    • Others

    By End-user
    • Adult
    • Pediatric

    By Distribution Channel
    • Hospitals
    • Ophthalmic clinics
    • Ambulatory surgical centers

    By Geography

    • North America
    o U.S.
    o Canada
    o Mexico

    • Europe
    o U.K
    o France
    o Germany
    o Italy
    o Spain
    o Rest of Europe

    • Asia-Pacific
    o China
    o Japan
    o India
    o Korea
    o Rest of APAC

    • South America
    o Brazil
    o Rest of South America

    • Rest of the World
    o Middle East
    o Africa

    keyboard_arrow_up
  • CHAPTER 1. INTRODUCTION
    1.1. RESEARCH METHODOLOGY
    1.1.1. ERC desk research
    1.1.2. ERC data synthesis
    1.1.3. Data validation and market feedback
    1.1.4. ERC data sources

    CHAPTER 2. OPTIC NEURITIS DRUG MARKET OVERVIEW
    2.1. OPTIC NEURITIS DRUG MARKET INTRODUCTION
    2.2. GLOBAL OPTIC NEURITIS DRUG MARKET PRODUCTION AND GROWTH RATE, 2017-2025
    2.2.1. Global Optic Neuritis Drug Production (VOLUME) and Growth Rate (%), (2017-2025)
    2.3. GLOBAL OPTIC NEURITIS DRUG MARKET CAPACITY AND GROWTH RATE, 2017-2025
    2.3.1. Global Optic Neuritis Drug Capacity (VOLUME) and Growth Rate (%), (2017-2025)
    2.4. GLOBAL OPTIC NEURITIS DRUG MARKET REVENUE AND GROWTH RATE, 2017-2025
    2.4.1. Global Optic Neuritis Drug Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
    2.5. GLOBAL OPTIC NEURITIS DRUG MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
    2.5.1. Global Optic Neuritis Drug Consumption (VOLUME) and Growth Rate (%), (2017-2025)
    2.6. GLOBAL OPTIC NEURITIS DRUG MARKET PRICE TREND, 2017-2025
    2.6.1. Global Optic Neuritis Drug Market Price Trend and Growth Rate (%), (2017-2025)

    CHAPTER 3. GLOBAL OPTIC NEURITIS DRUG MARKET BY TYPE, 2017-2025
    3.1. ORAL CORTICOSTEROID
    3.2. INTRAVENOUS CORTICOSTEROID
    3.3. OTHERS
    3.4. GLOBAL OPTIC NEURITIS DRUG MARKET REVENUE BY TYPE, 2017-2025
    3.4.1. Global Optic Neuritis Drug Market Revenue (Million USD) and Share (%) By Type, 2017-2025
    3.4.2. Oral corticosteroid Market Revenue and Growth Rate, 2017-2025
    3.4.3. Intravenous corticosteroid Market Revenue and Growth Rate, 2017-2025
    3.4.4. Others Market Revenue and Growth Rate, 2017-2025
    3.5. GLOBAL OPTIC NEURITIS DRUG MARKET PRODUCTION BY TYPE, 2017-2025
    3.5.1. Global Optic Neuritis Drug Market Production (Volume) and Share (%) By Type, 2017-2025
    3.5.2. Oral corticosteroid Market Production and Growth Rate, 2017-2025
    3.5.3. Intravenous corticosteroid Market Production and Growth Rate, 2017-2025
    3.5.4. Others Market Production and Growth Rate, 2017-2025

    Note: Similar information coverage has been provided for end user segment.

    CHAPTER 4. GLOBAL OPTIC NEURITIS DRUG MARKET BY DISTRIBUTION CHANNEL, 2017-2025
    4.1. HOSPITALS
    4.2. OPHTHALMIC CLINICS
    4.3. AMBULATORY SURGICAL CENTERS
    4.4. GLOBAL OPTIC NEURITIS DRUG MARKET REVENUE BY DISTRIBUTION CHANNEL, 2017-2025
    4.4.1. Global Optic Neuritis Drug Market Revenue (Million USD) and Share (%) By Distribution Channel, 2017-2025
    4.4.2. Hospitals Market Revenue and Growth Rate, 2017-2025
    4.4.3. Ophthalmic clinics Market Revenue and Growth Rate, 2017-2025
    4.4.4. Ambulatory surgical centers Market Revenue and Growth Rate, 2017-2025
    4.5. GLOBAL OPTIC NEURITIS DRUG MARKET CONSUMPTION BY DISTRIBUTION CHANNEL, 2017-2025
    4.5.1. Global Optic Neuritis Drug Market Consumption (Volume) and share (%) By Distribution Channel, 2017-2025
    4.5.2. Hospitals Market Consumption and Growth Rate, 2017-2025
    4.5.3. Ophthalmic clinics Market Consumption and Growth Rate, 2017-2025
    4.5.4. Ambulatory surgical centers Market Consumption and Growth Rate, 2017-2025

    CHAPTER 5. GLOBAL OPTIC NEURITIS DRUG MARKET BY REGION, 2017-2025
    5.1. NORTH AMERICA
    5.1.1. U.S.
    5.1.2. Canada
    5.1.3. Mexico
    5.2. EUROPE
    5.2.1. U.K.
    5.2.2. France
    5.2.3. Germany
    5.2.4. Italy
    5.2.5. Spain
    5.2.6. Rest of Europe
    5.3. ASIA PACIFIC
    5.3.1. China
    5.3.2. Japan
    5.3.3. India
    5.3.4. Korea
    5.3.5. Rest of APAC
    5.4. SOUTH AMERICA
    5.4.1. Brazil
    5.4.2. Rest of South America
    5.5. REST OF THE WORLD
    5.5.1. Middle East
    5.5.2. Africa
    5.6. GLOBAL OPTIC NEURITIS DRUG MARKET REVENUE BY REGION, 2017-2025
    5.6.1. Global Optic Neuritis Drug Market Revenue (Million USD) and Share (%) By Region, 2017-2025
    5.6.2. North America Market Revenue and Growth Rate, 2017-2025
    5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
    5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
    5.6.5. South America Market Revenue and Growth Rate, 2017-2025
    5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025

    CHAPTER 6. GLOBAL OPTIC NEURITIS DRUG MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
    6.1. GLOBAL OPTIC NEURITIS DRUG MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
    6.1.1. Global Optic Neuritis Drug Market Production (Volume) and Share (%) By Region, 2017-2025
    6.1.2. Global Optic Neuritis Drug Market Consumption (Volume) and Share (%) By Region, 2017-2025
    6.1.3. North America Market Production and Consumption, 2017-2025
    6.1.4. Europe Market Production and Consumption, 2017-2025
    6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
    6.1.6. South America Market Production and Consumption, 2017-2025
    6.1.7. Rest of the World Market Production and Consumption, 2017-2025

    CHAPTER 7. MARKET DETERMINANTS
    7.1. MARKET DRIVERS
    7.2. MARKET RESTRAINTS
    7.3. MARKET OPPORTUNITIES
    7.4. MARKET DETERMINANTS RADAR CHART

    CHAPTER 8. GLOBAL OPTIC NEURITIS DRUG MARKET COMPETITION BY MANUFACTURERS
    8.1. GLOBAL OPTIC NEURITIS DRUG PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
    8.1.1. Global Optic Neuritis Drug Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
    8.2. GLOBAL OPTIC NEURITIS DRUG REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
    8.2.1. Global Optic Neuritis Drug Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
    8.3. OPTIC NEURITIS DRUG MARKET COMPETITIVE SITUATION AND TRENDS
    8.3.1. Optic Neuritis Drug Market Share (%) of Top 3 Manufacturers
    8.3.2. Optic Neuritis Drug Market Share (%) of Top 5 Manufacturers

    CHAPTER 9. GLOBAL OPTIC NEURITIS DRUG MANUFACTURERS ANALYSIS
    9.1. AMGEN INC
    9.1.1. Business Overview
    9.1.2. Company Basic Information
    9.1.3. Optic Neuritis Drug Product Details
    9.1.4. Amgen Inc Optic Neuritis Drug Production, Revenue and Gross Margin
    9.2. BIOAXONE BIOSCIENCES INC
    9.2.1. Business Overview
    9.2.2. Company Basic Information
    9.2.3. Optic Neuritis Drug Product Details
    9.2.4. BioAxone BioSciences Inc Optic Neuritis Drug Production, Revenue and Gross Margin
    9.3. ALLERGAN PHARMACEUTICALS IRELAND
    9.3.1. Business Overview
    9.3.2. Company Basic Information
    9.3.3. Optic Neuritis Drug Product Details
    9.3.4. Allergan Pharmaceuticals Ireland Optic Neuritis Drug Production, Revenue and Gross Margin
    9.4. IRONWOOD PHARMACEUTICALS INC
    9.4.1. Business Overview
    9.4.2. Company Basic Information
    9.4.3. Optic Neuritis Drug Product Details
    9.4.4. Ironwood Pharmaceuticals Inc Optic Neuritis Drug Production, Revenue and Gross Margin
    9.5. SICOR SOCIETA’ ITALIANA CORTICOSTEROIDI S.R.L
    9.5.1. Business Overview
    9.5.2. Company Basic Information
    9.5.3. Optic Neuritis Drug Product Details
    9.5.4. Sicor Societa’ Italiana Corticosteroidi S.R.L Optic Neuritis Drug Production, Revenue and Gross Margin
    9.6. QUARK PHARMACEUTICALS INC
    9.6.1. Business Overview
    9.6.2. Company Basic Information
    9.6.3. Optic Neuritis Drug Product Details
    9.6.4. Quark Pharmaceuticals Inc Optic Neuritis Drug Production, Revenue and Gross Margin
    9.7. REGENERA PHARMA LTD
    9.7.1. Business Overview
    9.7.2. Company Basic Information
    9.7.3. Optic Neuritis Drug Product Details
    9.7.4. Regenera Pharma Ltd Optic Neuritis Drug Production, Revenue and Gross Margin
    9.8. NANG KUANG PHARMACEUTICAL
    9.8.1. Business Overview
    9.8.2. Company Basic Information
    9.8.3. Optic Neuritis Drug Product Details
    9.8.4. NANG KUANG PHARMACEUTICAL Optic Neuritis Drug Production, Revenue and Gross Margin
    9.9. PFIZER SA
    9.9.1. Business Overview
    9.9.2. Company Basic Information
    9.9.3. Optic Neuritis Drug Product Details
    9.9.4. PFIZER SA Optic Neuritis Drug Production, Revenue and Gross Margin
    9.10. NEWCHEM SPA
    9.10.1. Business Overview
    9.10.2. Company Basic Information
    9.10.3. Optic Neuritis Drug Product Details
    9.10.4. NEWCHEM SPA Optic Neuritis Drug Production, Revenue and Gross Margin

    CHAPTER 10. OPTIC NEURITIS DRUG MARKET VALUE CHAIN ANALYSIS
    10.1. OPTIC NEURITIS DRUG INDUSTRIAL CHAIN ANALYSIS
    10.2. OPTIC NEURITIS DRUG KEY RAW MATERIALS ANALYSIS
    10.2.1. Key Raw Materials
    10.2.2. Price Trend of Key Raw Materials
    10.2.3. Key Suppliers of Raw Materials
    10.3. MARKETING CHANNEL
    10.3.1. Direct Marketing
    10.3.2. Indirect Marketing
    10.3.3. Distributors/Traders
    10.4. CONSUMER ANALYSIS
    10.4.1. Consumer 1
    10.4.2. Consumer 2
    10.4.3. Consumer 3
    10.4.4. Consumer 4

    keyboard_arrow_up
  • • Amgen Inc
    • BioAxone BioSciences Inc
    • Allergan Pharmaceuticals Ireland
    • Ironwood Pharmaceuticals Inc
    • Sicor Societa’ Italiana Corticosteroidi S.R.L
    • Quark Pharmaceuticals Inc
    • Regenera Pharma Ltd
    • NANG KUANG PHARMACEUTICAL
    • PFIZER SA
    • NEWCHEM SPA
    • BIOFER S.P.A
    • Shandong Xinhua Pharmaceutical
    • Shanghai General Pharmaceutical
    • HPGC & CR Zizhu
    • Regeneron Pharmaceuticals Inc.

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

• What was the market size of the Optic Neuritis Drug Market in 2017 and the expected market size by 2025, along with the growth rate?
• An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
• Which are the largest revenue generating products, services or regions and their comparative growth rate?
• Which technology is in trend and how would it evolve during the forecast period (2017 – 2025)?
• Which are the leading companies in the Optic Neuritis Drug Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

CLIENTS